Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial

Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating that all subjects in the study will now receive the study medication (ACI-24 or Placebo) 8 times via s.c. injection instead of 7 times as previously mentioned.
    Difference
    0.1%
    Check dated 2024-06-06T14:23:57.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    45%
    Check dated 2024-05-22T19:18:04.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The value 'Go to the classic website Go to the classic website 5 2' on the webpage has been updated to 'type of intervention Site Map 6 0'. This change likely indicates a modification related to the type of intervention in medical and healthcare-related publications and documentation.
    Difference
    0.9%
    Check dated 2024-05-01T18:44:38.000Z thumbnail image

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.